Updated:
Rose Research Center
Rose Research Center operates clinical trial sites in Rockville, MD, and Raleigh, NC — a research-services organization for pharmaceutical sponsors.
Rose Research Center
Rose Research Center was established as a clinical research organization (CRO) with facilities in Rockville, Maryland, and Raleigh, North Carolina. Its founding context is not publicly detailed; the firm presents itself as a patient-centered clinical trial site network rather than an investment firm or family office. The organization contracts with pharmaceutical, biotechnology, and medical-device sponsors to conduct clinical studies across a range of therapeutic areas. Rose Research Center handles patient recruitment, informed consent, study coordination, and data collection — typical CRO site services. It does not disclose a fund structure or direct investment activity; it operates on a fee-for-service or per-patient revenue model. With two operational sites, Rose Research Center has not published its total trial volume, sponsor list, or financial performance. No information on team size, professionals, or additional offices is publicly available. The firm has not announced any recent operational events, partnerships, or expansions in the past 24 months. Rose Research Center's structural differentiator is its specialization as a dedicated clinical trial site network, a model distinct from asset-manager family offices or investment vehicles. Without disclosed ownership or wealth origin, its classification as a family office is uncertain; it may function as an operating company or research-services provider owned by private capital.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Rockville
Corporate office
Rockville, MD, United States
Additional offices
Raleigh, NC, United States
Sector focus
Frequently asked questions
What services does Rose Research Center provide?
Rose Research Center offers clinical trial site services for Phase I through Phase IV studies. It handles patient recruitment, informed consent, study coordination, and data collection under contracts with pharmaceutical and biotech sponsors. It does not invest capital or manage assets.
Is Rose Research Center structured as a family office?
The firm does not publicly describe itself as a family office. Its profile on Altss is categorized as such based on available data, but publicly it operates as a clinical research organization. No investment strategy, fund structures, or capital deployment are disclosed.
Where are Rose Research Center's facilities located?
The firm has clinical trial sites in Rockville, Maryland, and Raleigh, North Carolina. No additional locations or international expansion plans are publicly documented.
Who are the leadership principals at Rose Research Center?
Rose Research Center does not publicly list its leadership team or board of directors. No named operators or investors are identified in public records.
Does Rose Research Center make direct investments or fund commitments?
No. The firm does not disclose any direct investment activity, fund-of-fund commitments, or co-investment partnerships. Its revenue model is fee-for-service from clinical trial sponsors, not capital deployment.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: